• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AstraZeneca PLC - American Depositary Shares (NY:AZN)

182.85 +0.33 (+0.18%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,910,488
Open 182.71
Bid (Size) 180.00 (100)
Ask (Size) 182.90 (500)
Prev. Close 182.52
Today's Range 181.58 - 183.55
52wk Range 180.00 - 212.71
Shares Outstanding N/A
Dividend Yield 0.51%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Low-Cost ETF Holds Almost 8,800 Stocks Across Both Developed and Emerging Markets. Here's Why It's a Compelling Long-Term Core Holding ↗
May 07, 2026
If you're looking for diversification and value, here's a good ETF to check out. 
Via The Motley Fool
Topics ETFs
News headline image
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗
May 02, 2026
Via MarketBeat

Performance

YTD
-3.0%
-3.0%
1 Month
-10.5%
-10.5%
3 Month
-5.3%
-5.3%
6 Month
-3.0%
-3.0%
1 Year
-3.0%
-3.0%

More News

Read More
News headline image
TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer
April 30, 2026
From AstraZeneca
Via Business Wire
News headline image
AstraZeneca results: Q1 2026
April 29, 2026
From AstraZeneca
Via Business Wire
AstraZeneca (NYSE:AZN) Passes the Caviar Cruise Quality Screen with Strong Profitability and Growth ↗
April 24, 2026
Via Chartmill
News headline image
BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
April 28, 2026
From AstraZeneca
Via Business Wire
News headline image
SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus
April 27, 2026
From AstraZeneca
Via Business Wire
News headline image
Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗
April 27, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
April 20, 2026
From AstraZeneca
Via Business Wire
News headline image
Pictet Loads Up MercadoLibre With 3,500 Shares Worth $6.8 Million ↗
April 14, 2026
Via The Motley Fool
News headline image
Could AbbVie Crash Lilly's Weight‑Loss Party? ↗
April 14, 2026
Via The Motley Fool
News headline image
Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity
April 13, 2026
Via MarketMinute
Topics Economy
News headline image
Gilead Sciences Solidifies Oncology Future with $5 Billion Acquisition of ADC Innovator Tubulis
April 09, 2026
Via MarketMinute
Topics Bonds
News headline image
Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
April 03, 2026
Via MarketMinute
Topics Economy Government Lawsuit
News headline image
Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer
April 02, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer
April 02, 2026
From AstraZeneca
Via Business Wire
News headline image
Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
March 31, 2026
Via MarketMinute
Topics ETFs Intellectual Property Stocks
News headline image
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
March 31, 2026
Via Finterra
Topics Initial Public Offering
News headline image
AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results
March 27, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
March 27, 2026
From AstraZeneca
Via Business Wire
News headline image
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
March 25, 2026
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush
March 18, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Could This International ETF Be One of the Best Investments of 2026? ↗
March 14, 2026
Via The Motley Fool
Topics ETFs
News headline image
The 'Sentiment Trap': Why Beating Earnings Is No Longer Enough in the Age of AI Sentiment Analysis
March 13, 2026
Via MarketMinute
Topics Artificial Intelligence Earnings Regulatory Compliance
News headline image
The Billion-Dollar Divide: How "Megadeals" Are Defining a K-Shaped M&A Market in 2026
March 11, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Energy

Frequently Asked Questions

Is AstraZeneca PLC - American Depositary Shares publicly traded?
Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
What exchange does AstraZeneca PLC - American Depositary Shares trade on?
AstraZeneca PLC - American Depositary Shares trades on the New York Stock Exchange
What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the New York Stock Exchange
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 182.85
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 05/08/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap